Janssen-developed clinical trials tech available for industry use

By Melissa Fassbender

- Last updated on GMT

Janssen Research & Development collaborated with Tata Consultancy Services (TCS) to build out the clinical trials platform. (Image: iStock/utah778)
Janssen Research & Development collaborated with Tata Consultancy Services (TCS) to build out the clinical trials platform. (Image: iStock/utah778)

Related tags Clinical trial Clinical trials Clinicaltrials.gov

The new Software as a Service (SaaS) solution provides tools for clinical trials medication management and patient engagement.

The new platform features four modules including, communication, adherence, label, and tracking

The approach was developed by Janssen Research & Development as part of its integrated Smart Trial and Engagement Platform (iSTEP) initiative and will be made available for industry-use via Tata Consultancy Services (TCS) under the name Connected Clinical Trials (CCT).

Drug accountability and medication management are the most complex elements of a clinical trial. CCT automates this entire process and thereby removes guesswork from the clinical trial​,” a TCS spokesperson told Outsourcing-Pharma.com.

Moreover, CCT leverages a powerful device data acquisition and analytical framework that helps a clinical trial benefit from a variety of devices on a single platform. Each trial is unique in itself and CCT helps study teams flexibly manage variation across trials through extensive configuration capability​.”

The platform has been tested and proven in a live set-up at TCS' User Experience labs with global patient and site advisory boards in collaboration with the Center for Information and Study on Clinical Research Participation (CISCRP).

Additionally, Janssen has conducted a technical pilot and is working with health authorities and ethics committees to implement a pilot assessment of the technology in a clinical trial by the end of 2017.

Janssen plans to gradually implement iSTEP into clinical trials in its portfolio, according to the company.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us

Products

View more

Webinars